Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
196170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7196170005
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
- Website:
- http://www.alteogen.com/
Description
Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-11 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.8 KB | ||
| 2024-03-11 00:00 |
주주총회소집공고
|
Korean | 215.2 KB | ||
| 2024-03-11 00:00 |
주주총회소집결의
|
Korean | 15.7 KB | ||
| 2024-02-26 00:00 |
기업설명회(IR)개최
|
Korean | 8.2 KB | ||
| 2024-02-22 00:00 |
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 라이센스 변경계약의 체결)
|
Korean | 10.2 KB | ||
| 2024-01-05 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2023-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2023-11-14 00:00 |
분기보고서 (2023.09)
|
Korean | 1.9 MB | ||
| 2023-10-31 00:00 |
기업설명회(IR)개최
|
Korean | 7.1 KB | ||
| 2023-09-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2023-08-11 00:00 |
반기보고서 (2023.06)
|
Korean | 1.8 MB | ||
| 2023-05-31 00:00 |
투자판단관련주요경영사항(ALT-B4 관련 마일스톤 기술료 수령)
|
Korean | 9.0 KB | ||
| 2023-05-15 00:00 |
분기보고서 (2023.03)
|
Korean | 1.8 MB | ||
| 2023-04-05 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 138.4 KB | ||
| 2023-04-04 00:00 |
투자판단관련주요경영사항(ALT-B4 관련 마일스톤 기술료 수령)
|
Korean | 9.1 KB |
Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alteogen Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alteogen Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
